Company Overview and News

 
Five stocks to put in the trash during spring cleaning - MarketWatch

2018-04-20 marketwatch
The doom and gloom of a few days ago in the U.S. stock market has been bolstered by stability and optimism.
Upvote Downvote

 
Will Cost Cut, Innovations Drive Coca-Cola (KO) Q1 Earnings?

2018-04-20 zacks
The Coca-Cola Company (KO - Free Report) is slated to report first-quarter 2018 results on Apr 24, before the opening bell. Last quarter, the company delivered a positive earnings surprise of 2.63%. In fact, this beverage giant delivered a positive earnings surprise in three of the trailing four quarters, with the average beat being 1.48%. A Look at Coca-Cola’s Revenue Performance Coca-Cola has been struggling to boost sales amid weak demand in certain emerging and developing markets, and shifting consumer preferences.
Upvote Downvote

 
UPDATE 1-N. American Q1 cocoa grind shows weakest start in 7 years

2018-04-19 reuters
TORONTO (Reuters) - North American cocoa grindings fell in the first quarter of 2018, marking the region’s weakest start to the calendar year since 2011, data from the National Confectioners Association (NCA) showed on Thursday.
Upvote Downvote

 
Palantir Knows Everything About You

2018-04-19 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Hershey Co Has Become a Molten, Gooey Mess

2018-04-18 investorplace
In retrospect, long-term owners of Hershey Co (NYSE:HSY) are likely wishing they’d taken the sweet buyout offer they got from Mondelez International Inc (NASDAQ:MDLZ) back in 2016. The rival candy and food company was willing to pay $107 per share of Hershey stock at the time. Now it’s trading at less than $97 per share while the broad market is much, much higher for the same timeframe.
Upvote Downvote

 
Can Improved Sales Aid Procter & Gamble (PG) in Q3 Earnings?

2018-04-18 zacks
The Procter & Gamble Company (PG - Free Report) is set to report third-quarter fiscal 2018 results on Apr 20, before market opens. Last quarter, the company delivered a positive earnings surprise of 3.48%. In fact, this consumer goods company delivered a positive earnings surprise in each of the trailing four quarters, the average beat being 4.11%. Factors to Consider Weak volumes and slowing market share growth have been hurting sales of Procter & Gamble for quite some time.
Upvote Downvote

 
32 'Safer' Dividend Consumer Defensive Stocks For April, 2019

2018-04-13 seekingalpha
32 of 91 top yield Consumer Defensive stocks were tagged "safer" because they showed positive annual-returns, and free cash-flow yields greater than their dividend yields.
Upvote Downvote

 
Walmart Relaxes Deadlines for Some Deliveries Amid Driver Crunch - Bloomberg

2018-04-11 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Top Analyst Upgrades and Downgrades: Alphabet, Cognex, Facebook, Monsanto, Netflix, Nvidia, Tesla, Ulta, Zscaler and More

2018-04-10 247wallst
Stocks closed up on Monday, but far lower than the midday highs. Stocks were then indicated up large on Tuesday morning in an effort to recapture those gains. The bull market is now over nine years old, and the trend of buying pullbacks has become much more vulnerable to sellers and volatility trades. The climate has become more difficult for investors trying to decide how they want their assets positioned for the rest of 2018 and beyond.
Upvote Downvote

 
Alterna CEO embraced weed business when nobody else would

2018-04-06 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
Upvote Downvote

 
Hershey to Webcast First-Quarter Conference Call

2018-04-04 globenewswire
HERSHEY, Pa., April 04, 2018 (GLOBE NEWSWIRE) -- The Hershey Company (NYSE:HSY) announced today that it will release its first-quarter sales and earnings results on Thursday, April 26, 2018, and hold a conference call with analysts at 8:30 a.m. ET on that date. The company will webcast live its first-quarter conference call via the Hershey corporate website. Please click here and navigate to “CALENDAR OF EVENTS” for webcast details.
Upvote Downvote

 
Hershey to Spend $500 Million Making More Sustainable Kisses - Bloomberg

2018-04-03 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

1
Weed Is Serious Business for Canada’s Go-To Pot Banker - Bloomberg

2018-04-03 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Hershey Announces Cocoa For Good, the Company’s Half-Billion Dollar Sustainable Cocoa Strategy

2018-04-03 globenewswire
HERSHEY, Pa., April 03, 2018 (GLOBE NEWSWIRE) -- The Hershey Company (NYSE:HSY) today announced Cocoa For Good, its holistic cocoa sustainability strategy. The comprehensive strategy addresses the most pressing issues facing cocoa-growing communities: poverty, poor nutrition, at-risk youth, and vulnerable ecosystems. Hershey seeks to bring positive change in these areas through collaborative programs, partnerships and significant investment, including a half-a-billion-dollar commitment by 2030.
Upvote Downvote

 
3Pea: Strong Guidance, Uplisting, Should Propel Shares Higher

2018-04-03 seekingalpha
Management's guidance for 2018 calls for growth to meet or exceed the growth experienced in 2017.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...